Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Editor's Pick

Iron Law of Prohibition: Nicotine Edition

by
May 30, 2024
in Editor's Pick
0
Iron Law of Prohibition: Nicotine Edition
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Jeffrey A. Singer

In 2016, the Food and Drug Administration (FDA) assumed the authority to regulate all nicotine‐​containing products, including electronic nicotine delivery systems, such as e‑cigarettes. E‑cigarette manufacturers were given until September 9, 2020, to submit applications to the FDA for the agency to approve the marketing of their products. The agency received nearly seven million applications by the deadline and is still reviewing many of them. It has rejected more than a million flavored vape applications.

However, non‐​nicotine synthetics that have chemical structures resembling nicotine are exempt from FDA regulation. Thus, people who wish to consume relatively harmless nicotine because they value its stimulative and calming effects can work around government obstructions by accessing nicotine‐​analog products. The government does not require makers of synthetic nicotine analogs to obtain FDA approval before they can market them to consumers. And consumers are purchasing these products.

According to a letter to FDA Commissioner Robert Califf, MD, from Altria LLC, a nicotine product manufacturer that has complied with FDA regulations, several companies, including many in other countries, are marketing nicotine analogs to consumers. The letter states, “The introduction and growth of chemicals intended to imitate the effects of nicotine, if left unchecked, could present unknown risks to U.S. consumers and undermine FDA’s authority,” urging the FDA to “carefully and quickly evaluate these new compounds to determine what regulatory authority it has over these products.”

Now comes a report by the Reuters news agency stating that the FDA and independent researchers believe that many of these analogs, such as 6‑methyl nicotine, might be “more potent and addictive” than nicotine.

This is another example of the “iron law of prohibition”—the harder the law enforcement, the harder the drug—in action. In this case, the government, largely driven by nicotinophobia, is prohibiting the manufacture and sale of numerous nicotine products, many of which have helped smokers quit the habit.

Prohibition resulted in drug trafficking organizations moving from diverted prescription pain pills to heroin, from heroin to fentanyl, from fentanyl to fentanyl mixed with xylazine, and now from that to fentanyl mixed with medetomidine and nitazenes.

Rinse and repeat.

We are now seeing the same process at work with nicotine. Nicotine prohibition begets more potent forms of nicotine, and new opportunities appear to be on the horizon for the prohibition/​law enforcement complex.

Previous Post

Introducing Sofia Tech One: The Next Evolution in Office Buildings

Next Post

Information Security Commitment Strengthened as Ultra Support Attains ISO-27001 Certification

Next Post

Information Security Commitment Strengthened as Ultra Support Attains ISO-27001 Certification

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021

Rescue Dogs Strut the Runway in Search of Their Forever Homes

0

0

0

0

Rescue Dogs Strut the Runway in Search of Their Forever Homes

July 4, 2025
UK Finance urges bold reforms in Mansion House 2025 submission to unlock UK growth potential

UK Finance urges bold reforms in Mansion House 2025 submission to unlock UK growth potential

July 4, 2025
Propel Finance secures £1.5bn to boost UK SME lending

Propel Finance secures £1.5bn to boost UK SME lending

July 4, 2025
MPs slam Home Office for failing to track foreign workers after visa expiry

MPs slam Home Office for failing to track foreign workers after visa expiry

July 4, 2025

Recent News

Rescue Dogs Strut the Runway in Search of Their Forever Homes

July 4, 2025
UK Finance urges bold reforms in Mansion House 2025 submission to unlock UK growth potential

UK Finance urges bold reforms in Mansion House 2025 submission to unlock UK growth potential

July 4, 2025
Propel Finance secures £1.5bn to boost UK SME lending

Propel Finance secures £1.5bn to boost UK SME lending

July 4, 2025
MPs slam Home Office for failing to track foreign workers after visa expiry

MPs slam Home Office for failing to track foreign workers after visa expiry

July 4, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.